Cameron King, DO
Orthopaedic Surgery · New Orleans, LANPI 1790280972
Payments from drug & device makers
What this record shows
This record is dominated by grants: $46,667 of the $73,885 with a category attached, or 63.2%. 18 manufacturers reported payments, led by Linvatec Corporation at 32.0% of the total. Reporting peaked in 2024 at $30,137 and has fallen 97.3% since, to $819 in 2025. Among orthopaedic surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $684.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$24K
- Arthrex$21K
- Pinnacle, Inc$18K
- Smith+Nephew$7K
- Stryker$2K
- Zimmer Biomet$795
- plus $1K from 12 others
What the payments were for
- Grants$46,66763%
- Travel & lodging$2,1983%
- Food & beverage$3,7275%
- Education$21,29329%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 3 | $23,626 |
| Arthrex | 19 | $21,333 |
| Pinnacle, Inc | 32 | $18,006 |
| Smith+Nephew | 2 | $6,667 |
| Stryker | 13 | $2,008 |
| Zimmer Biomet | 14 | $795 |
| Avanos Medical | 4 | $440 |
| Goode Surgical Inc | 10 | $362 |
| Sanara Medtech Inc. | 1 | $144 |
| Osteocentric Technologies, Inc. | 1 | $138 |
| Davol Inc. | 1 | $119 |
| Pacira Pharmaceuticals Incorporated | 1 | $118 |
| Johnson & Johnson | 2 | $46 |
| Curonix LLC | 1 | $21 |
| ALON Medical Technology | 1 | $19 |
| Kerecis Limited | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $15 |
| Si-bone, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$73,885 in reported general payments places this provider in the 90th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 29 | $422 |
| Meloxicam | 57 | $127 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New Orleans
- Robert ZuraNew Orleans$597K
- Fernando SanchezNew Orleans$484K
- Matthew CableNew Orleans$79K
- Gustavo GodoyNew Orleans$76K
- Ramin SadeghpourNew Orleans$37K
- Robert HuangNew Orleans$28K
- Leland McCluskeyNew Orleans$24K
- Willard MooreNew Orleans$23K
- Jessica RiveraNew Orleans$20K
- Richard MeyerNew Orleans$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.